These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 8120343
1. Electrophysiological and autoradiographical evidence for cholecystokinin A receptors on rat isolated nodose ganglia. Widdop RE, Krstew E, Mercer LD, Carlberg M, Beart PM, Jarrott B. J Auton Nerv Syst; 1994; 46(1-2):65-73. PubMed ID: 8120343 [Abstract] [Full Text] [Related]
2. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Corp ES, McQuade J, Moran TH, Smith GP. Brain Res; 1993 Sep 24; 623(1):161-6. PubMed ID: 8221086 [Abstract] [Full Text] [Related]
3. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle. Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW. Br J Pharmacol; 1995 Jan 24; 114(2):339-48. PubMed ID: 7881733 [Abstract] [Full Text] [Related]
4. Autoradiographic Localization of Cholecystokinin A and B Receptors in Rat Brain Using [125I]d-Tyr25 (Nle28,31)-CCK 25 - 33S. Carlberg M, Gundlach AL, Mercer LD, Beart PM. Eur J Neurosci; 1992 Jan 24; 4(6):563-573. PubMed ID: 12106342 [Abstract] [Full Text] [Related]
5. Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain. Boden PR, Woodruff GN, Pinnock RD. Br J Pharmacol; 1991 Mar 24; 102(3):635-8. PubMed ID: 1364831 [Abstract] [Full Text] [Related]
6. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes. You ZB, Godukhin O, Goiny M, Nylander I, Ungerstedt U, Terenius L, Hökfelt T, Herrera-Marschitz M. Naunyn Schmiedebergs Arch Pharmacol; 1997 May 24; 355(5):576-81. PubMed ID: 9151295 [Abstract] [Full Text] [Related]
7. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat. Gronier B, Debonnel G. Synapse; 1995 Oct 24; 21(2):158-68. PubMed ID: 8584977 [Abstract] [Full Text] [Related]
9. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells. Meyer G, Beinborn M, Sewing KF. Pharmacology; 1996 Jul 23; 53(1):48-59. PubMed ID: 8875601 [Abstract] [Full Text] [Related]
10. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide. Boyle SJ, Tang KW, Woodruff GN, McKnight AT. Br J Pharmacol; 1993 Aug 23; 109(4):913-7. PubMed ID: 8401944 [Abstract] [Full Text] [Related]
11. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models. Ballaz S, Barber A, Fortuño A, Del Río J, Martin-Martínez M, Gómez-Monterrey I, Herranz R, González-Muñiz R, García-López MT. Br J Pharmacol; 1997 Jun 23; 121(4):759-67. PubMed ID: 9208145 [Abstract] [Full Text] [Related]
12. Control of gallbladder contractions by cholecystokinin through cholecystokinin-A receptors in the vagal pathway and gallbladder in the dog. Sonobe K, Sakai T, Satoh M, Haga N, Itoh Z. Regul Pept; 1995 Dec 07; 60(1):33-46. PubMed ID: 8747782 [Abstract] [Full Text] [Related]
13. Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve. Mercer JG, Lawrence CB. Neurosci Lett; 1992 Mar 30; 137(2):229-31. PubMed ID: 1374868 [Abstract] [Full Text] [Related]
14. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260. O'Neill MF, Dourish CT, Iversen SD. Eur J Pharmacol; 1991 Feb 07; 193(2):203-8. PubMed ID: 2050197 [Abstract] [Full Text] [Related]
15. CCK-8-stimulated insulin secretion in vivo is mediated by CCKA receptors. Karlsson S, Ahrén B. Eur J Pharmacol; 1992 Mar 17; 213(1):145-6. PubMed ID: 1499651 [Abstract] [Full Text] [Related]
16. Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning. Mosher JT, Johnson MF, Birkemo LS, Ervin GN. Peptides; 1996 Mar 17; 17(3):483-8. PubMed ID: 8735976 [Abstract] [Full Text] [Related]
17. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat. Mönnikes H, Lauer G, Arnold R. Brain Res; 1997 Oct 03; 770(1-2):277-88. PubMed ID: 9372230 [Abstract] [Full Text] [Related]
18. Electrophysiological studies of the cholecystokininA receptor antagonists SR27897B and PD140548 in the rat isolated nodose ganglion. Beart PM, Krstew E, Widdop RE. Naunyn Schmiedebergs Arch Pharmacol; 1996 May 03; 353(6):693-7. PubMed ID: 8738304 [Abstract] [Full Text] [Related]
19. Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin. Corwin RL, Smith GP. Peptides; 1993 May 03; 14(2):253-7. PubMed ID: 8483804 [Abstract] [Full Text] [Related]